Log In
Print
BCIQ
Print
Print this Print this
 

M2SR, REDEE FLU

  Manage Alerts
Collapse Summary General Information
Company FluGen Inc.
DescriptionReplication-deficient live attenuated vaccine based on the deletion of the influenza A virus matrix protein 2 (M2) gene
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H5N1 avian influenza infection
Regulatory Designation

Partner

Arecor Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today